NICE guidance: why not clozapine for treatment-refractory bipolar disorder?

被引：0
|
作者：
Bastiampillai, Tarun [1 ,2 ,3 ]
Gupta, Arun [4 ]
Allison, Stephen [3 ]
Chan, Sherry Kit Wa [5 ,6 ]
机构：
[1] South Australian Hlth & Med Res Inst, Adelaide, SA 5000, Australia
[2] Govt South Australia, SA Hlth, Mental Hlth Strategy, Adelaide, SA, Australia
[3] Flinders Univ S Australia, Dept Psychiat, Adelaide, SA, Australia
[4] Flinders Med Ctr, Dept Psychiat, Adelaide, SA, Australia
[5] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China
[6] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China
来源：
LANCET PSYCHIATRY | 2016年 / 3卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：502 / 503
页数：3
相关论文
共 50 条
  • [21] NICE guidance on psychological treatments for bipolar disorder
    Kendall, Tim
    Morriss, Richard
    Mayo-Wilson, Evan
    Meyer, Thomas D.
    Jones, Steven H.
    Oud, Matthijs
    Baker, Mark R.
    LANCET PSYCHIATRY, 2016, 3 (04): : 317 - 320
  • [22] Haloperidol in combination with clozapine in treatment-refractory patients with schizophrenia
    Mossaheb, N.
    Sacher, J.
    Wiesegger, G.
    Klein, N.
    Spindelegger, C. J.
    Asenbaum, S.
    Dudczak, R.
    Kasper, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S416 - S416
  • [23] A pharmacoeconomic analysts of clozapine therapy in treatment-refractory schizophrenia
    Konicki, PE
    Manuel, M
    Kwon, K
    Jurjus, G
    Jaskiw, GE
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 186 - 186
  • [24] Effects of clozapine on cognitive functions in treatment-refractory schizophrenia
    Stone, WS
    Seidman, LJ
    Kalinowski, A
    Shagrin, B
    Patel, JK
    Shafa, R
    Canuso, C
    Schildkraut, JJ
    Green, AI
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 188 - 189
  • [25] Underuse and Suboptimal Use of Clozapine in Treatment-Refractory Schizophrenia
    Shad, Mujeeb U.
    PSYCHIATRIC ANNALS, 2021, 51 (12) : 576 - 578
  • [26] Thalamic activity and clozapine response in treatment-refractory patients
    Molina, V
    Lampreave, JL
    Montz, R
    Sanz, J
    Desco, M
    Collazos, F
    Benito, C
    Maldonado, F
    Palomo, T
    Carreras, JL
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 228 - 229
  • [27] The effects of clozapine on symptom clusters in treatment-refractory patients
    Abraham, G
    Nair, C
    Tracy, JI
    Simpson, GM
    Josiassen, RC
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) : 49 - 53
  • [28] Neutropenia and agranulocytosis in treatment-refractory adolescents receiving clozapine
    Kranzler, HN
    Gerbino-Rosen, G
    Tompkins, DA
    Feryo, D
    Nussbaum, L
    Roofeh, D
    Fisch, G
    Frederickson, A
    Napolitano, B
    Kumra, S
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 565 - 565
  • [29] CLINICAL EFFICACY OF CLOZAPINE IN TREATMENT-REFRACTORY SCHIZOPHRENIA - AN OVERVIEW
    KANE, JM
    BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 : 41 - 45
  • [30] Treatment-refractory obsessive compulsive disorder
    Atmaca, Murad
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 70 : 127 - 133
12345